Journey Medical CorporationDERMNASDAQ
Loading
Year-over-year net income growth rate
Percentile
P69
Within normal range
vs 2Y Ago
0.1x
Contraction
Streak
2 qtr
Consecutive growthRecovering
| Period | Value |
|---|---|
| Q3 2025 | 39.01% |
| Q2 2025 | 6.80% |
| Q1 2025 | -367.78% |
| Q4 2024 | 163.64% |
| Q3 2024 | 28.89% |
| Q2 2024 | 67.81% |
| Q1 2024 | -387.26% |
| Q4 2023 | -112.76% |
| Q3 2023 | 300.75% |
| Q2 2023 | 17.49% |
| Q1 2023 | 4.75% |
| Q4 2022 | -5.58% |
| Q3 2022 | -33.90% |
| Q2 2022 | -446.30% |
| Q1 2022 | 93.66% |
| Q4 2021 | -104.31% |
| Q3 2021 | 10.27% |
| Q2 2021 | -4527.24% |
| Q1 2021 | -89.29% |
| Q4 2020 | 8527.59% |
| Q3 2020 | -93.63% |
| Q2 2020 | -66.93% |
| Q1 2020 | 0.00% |
| Q3 2019 | -220.79% |
| Q2 2019 | 72.29% |
| Q1 2019 | 9.72% |
| Q4 2018 | -7.91% |
| Q3 2018 | -178.05% |
| Q2 2018 | 59.61% |
| Q1 2018 | -5.79% |
| Q4 2017 | 68.74% |
| Q3 2017 | -364.59% |
| Q2 2017 | -30.69% |
| Q1 2017 | -299.69% |
| Q4 2016 | 71.06% |
| Q3 2016 | 54.60% |
| Q2 2016 | -97.61% |
| Q1 2016 | 63.73% |
| Q4 2015 | -388.35% |
| Q3 2015 | 48.53% |